AI Article Synopsis
- Invasive fungal infections can worsen outcomes in COVID-19 patients, leading to higher risks of complications and death.
- A 59-year-old man with serious health issues developed severe respiratory problems from COVID-19 and was treated with powerful immunosuppressants.
- He was later diagnosed with fungal infections, suggesting that his underlying conditions and aggressive treatment made him more vulnerable to these opportunistic infections.
Article Abstract
Invasive fungal infections may complicate infection by SARS-CoV-2 and increase morbidity and mortality. A 59-year-old man with multiple medical comorbidities was transferred to our hospital for worsening hypoxic respiratory failure due to COVID-19 and received high-dose corticosteroids and 2 doses of cyclophosphamide. He was diagnosed with pulmonary aspergillosis and cryptococcosis by culture of a bronchoalveolar lavage sample. This patient's secondary infections were likely due to treatment with immunosuppressants, his comorbidities, and his prolonged critical illness.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734106 | PMC |
| http://dx.doi.org/10.1016/j.mmcr.2022.01.003 | DOI Listing |
Publication Analysis
Top Keywords
pulmonary aspergillosis
8
aspergillosis cryptococcosis
8
cryptococcosis complication
4
complication covid-19
4
covid-19 invasive
4
invasive fungal
4
fungal infections
4
infections complicate
4
complicate infection
4
infection sars-cov-2
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!